Unknown

Dataset Information

0

The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension.

ABSTRACT:

SUBMITTER: Forzano I 

PROVIDER: S-EPMC9780529 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension.

Forzano Imma I   Mone Pasquale P   Varzideh Fahimeh F   Jankauskas Stanislovas S SS   Kansakar Urna U   De Luca Antonio A   Santulli Gaetano G  

Frontiers in endocrinology 20221209

Similar Datasets

Unknown Discovery of Spirocyclic Aldosterone Synthase Inhibitors as Potential Treatments for Resistant Hypertension.
| S-EPMC5238464 | biostudies-literature
Unknown Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
| S-EPMC7618089 | biostudies-literature
Unknown Fenofibrate lowers blood pressure in salt-sensitive but not salt-resistant hypertension.
| S-EPMC3800119 | biostudies-literature
Unknown Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects.
| S-EPMC9930700 | biostudies-literature
Unknown Efficacy and Safety of Aldosterone Synthase Inhibitors for Resistant Hypertension: A Systematic Review and Meta-Analysis.
| S-EPMC12415759 | biostudies-literature
Unknown Results from a phase 1, randomized, double-blind, multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers.
| S-EPMC9747611 | biostudies-literature
Unknown Development of Highly Selective Pyrimidine-Based Aldosterone Synthase (CYP11B2) Inhibitors.
| S-EPMC6628572 | biostudies-literature
Unknown Washed Microbiota Transplantation Lowers Blood Pressure in Patients With Hypertension.
| S-EPMC8385408 | biostudies-literature
Unknown Targeting cytokine-like protein FAM3D lowers blood pressure in hypertension.
| S-EPMC10313939 | biostudies-literature
Unknown First-in-human study evaluating safety, pharmacokinetics, and pharmacodynamics of lorundrostat, a novel and highly selective aldosterone synthase inhibitor.
| S-EPMC11329366 | biostudies-literature